10790
安替吡啉
≥99.0% (RT)
别名:
2,3-二甲基-1-苯基-3-吡唑啉-5-酮, 非那宗
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C11H12N2O
化学文摘社编号:
分子量:
188.23
EC Number:
200-486-6
UNSPSC Code:
12352200
PubChem Substance ID:
Beilstein/REAXYS Number:
157775
MDL number:
assay
≥99.0% (RT)
form
crystals
mp
109-111 °C (lit.), 109-114 °C
SMILES string
CN1N(C(=O)C=C1C)c2ccccc2
InChI
1S/C11H12N2O/c1-9-8-11(14)13(12(9)2)10-6-4-3-5-7-10/h3-8H,1-2H3
InChI key
VEQOALNAAJBPNY-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under 安替吡啉
法规信息
新产品
此项目有
Gro Klitgaard Povlsen et al.
BMC neuroscience, 14, 34-34 (2013-03-19)
Upregulation of vasoconstrictor receptors in cerebral arteries, including endothelin B (ETB) and 5-hydroxytryptamine 1B (5-HT(1B)) receptors, has been suggested to contribute to delayed cerebral ischemia, a feared complication after subarachnoid hemorrhage (SAH). This receptor upregulation has been shown to be
Antipyrine as a model drug to study hepatic drug-metabolizing capacity.
H E Poulsen et al.
Journal of hepatology, 6(3), 374-382 (1988-06-01)
Factors influencing antipyrine elimination.
I H Stevenson
British journal of clinical pharmacology, 4(3), 261-265 (1977-06-01)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 300098-25G | 04061826657843 |
| 300098-5G | 04061826657850 |